Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for prostate cancer.

M K Brawer1

  • 1Northwest Prostate Institute, Northwest Hospital, Seattle, Washington 98133, USA. mbrawer@nwhsea.org

Seminars in Surgical Oncology
|January 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Evidence: Non-metastatic prostate cancer.

The Western journal of medicine·2008
Same author

Modern brachytherapy for localized prostate cancers: the northwest hospital (Seattle) experience.

Reviews in urology·2006
Same author

Letter from the editors of reviews in urology.

Reviews in urology·2006
Same author

Evaluation and treatment of men with biochemical prostate-specific antigen recurrence following definitive therapy for clinically localized prostate cancer.

Reviews in urology·2006
Same author

Readership survey: reviews in urology.

Reviews in urology·2006
Same author

New urologic strategies explored at jackson hole: highlights from the 20th annual jackson hole urologic conference january 22-28, 2000, jackson hole, wyo.

Reviews in urology·2006

Prostate cancer screening, using digital rectal exams (DRE) and prostate-specific antigen (PSA) tests, shows promise for early detection. However, definitive proof of reduced mortality is still needed, requiring careful patient counseling on benefits and risks.

Area of Science:

  • Urology
  • Oncology
  • Preventive Medicine

Background:

  • Prostate cancer screening offers potential for early detection and curable treatment.
  • Significant uncertainties remain regarding the impact of screening on prostate cancer mortality.
  • Current screening methods include digital rectal examination (DRE) and prostate-specific antigen (PSA) testing.

Purpose of the Study:

  • To review the literature on prostate cancer screening methods.
  • To discuss the benefits, limitations, and potential liabilities of early detection.
  • To inform counseling for patients regarding screening decisions.

Main Methods:

  • Review of salient scientific literature on prostate cancer screening.
  • Analysis of the benefits and risks associated with DRE and PSA testing.

Related Experiment Videos

  • Commentary on the current state of knowledge regarding screening efficacy.

    • Main Results:

    • Early detection via DRE and PSA may benefit informed patients with a 10-year life expectancy.
    • Considerable controversy exists regarding the definitive impact of screening on mortality.
    • Definitive proof of decreased prostate cancer mortality from screening is pending.

    Conclusions:

    • Men with at least a 10-year life expectancy should receive counseling on prostate cancer screening benefits and risks.
    • Further research is needed to demonstrate a clear reduction in prostate cancer mortality.
    • Informed decision-making is crucial until conclusive evidence is established.